Five-Year Survival Data from a Pivotal Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

Barbara Pro; Ranjana H. Advani; Pauline Brice; Nancy L. Bartlett; Joseph D. Rosenblatt; Tim Illidge; Jeffrey Matous; Radhakrishnan Ramchandren; Michelle A. Fanale; Joseph M. Connors; Keenan Fenton; Dirk Huebner; Juan Pinelli; Andrei R. Shustov

Five-Year Survival Data from a Pivotal Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

Barbara Pro, Ranjana H. Advani, Pauline Brice, Nancy L. Bartlett, Joseph D. Rosenblatt, Tim Illidge, Jeffrey Matous, Radhakrishnan Ramchandren, Michelle A. Fanale, Joseph M. Connors, Keenan Fenton, Dirk Huebner, Juan Pinelli, Andrei R. Shustov

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Journal	Blood
Volume	128
Issue number	22
Publication status	Published - 2 Dec 2016

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Pro, B., Advani, R. H., Brice, P., Bartlett, N. L., Rosenblatt, J. D., Illidge, T., Matous, J., Ramchandren, R., Fanale, M. A., Connors, J. M., Fenton, K., Huebner, D., Pinelli, J., & Shustov, A. R. (2016). Five-Year Survival Data from a Pivotal Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma. Blood, 128(22).

@article{74fe4021368141368919c60c0dd21ece,

title = "Five-Year Survival Data from a Pivotal Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma",

author = "Barbara Pro and Advani, {Ranjana H.} and Pauline Brice and Bartlett, {Nancy L.} and Rosenblatt, {Joseph D.} and Tim Illidge and Jeffrey Matous and Radhakrishnan Ramchandren and Fanale, {Michelle A.} and Connors, {Joseph M.} and Keenan Fenton and Dirk Huebner and Juan Pinelli and Shustov, {Andrei R.}",

year = "2016",

month = dec,

day = "2",

language = "English",

volume = "128",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "22",

}

TY - JOUR

T1 - Five-Year Survival Data from a Pivotal Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

AU - Pro, Barbara

AU - Advani, Ranjana H.

AU - Brice, Pauline

AU - Bartlett, Nancy L.

AU - Rosenblatt, Joseph D.

AU - Illidge, Tim

AU - Matous, Jeffrey

AU - Ramchandren, Radhakrishnan

AU - Fanale, Michelle A.

AU - Connors, Joseph M.

AU - Fenton, Keenan

AU - Huebner, Dirk

AU - Pinelli, Juan

AU - Shustov, Andrei R.

PY - 2016/12/2

Y1 - 2016/12/2

M3 - Meeting Abstract

SN - 0006-4971

VL - 128

JO - Blood

JF - Blood

IS - 22

ER -